Suchergebnisse - "Subramanian, Sreedhar"

PubPharm (14)

1

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE) : a multicentre, open-label randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Noor, N. | Lee, J. | Bond, S. | +40

2

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite) : an open-label, multicentre, randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Lindsay, J. | Hind, D. | Swaby, L. | +30

3

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic : the PREPARE-IBD multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Saifuddin, A. | Kent, A. | Mehta, S. | +113

CommentIn: Aliment Pharmacol Ther. 2023 Jan;57(1):156-157. - PMID 36468219

4

Safety and effectiveness of ustekinumab in elderly Crohn's disease patients

enthalten in: European journal of gastroenterology & hepatology | 2022

von Fiske, J. | Liu, E. | Limdi, J. | +12

5

Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13] : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2022

von Smith, P. | Critchley, L. | Storey, D. | +17

6

Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients : insights from a multicentre UK cohort study

enthalten in: BMJ open gastroenterology | 2022

von Sebastian, S. | Patel, K. | Segal, J. | +13

7

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC) : a multicentre, observational, case-control study

enthalten in: The lancet. Gastroenterology & hepatology | 2021

von Sebastian, S. | Walker, G. | Kennedy, N. | +112

CommentIn: Lancet Gastroenterol Hepatol. 2021 Apr;6(4):254-255. - PMID 33545082

8

Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Townsend, T. | Razanskaite, V. | Dodd, S. | +14

CommentIn: Aliment Pharmacol Ther. 2021 Jan;53(2):360-361. - PMID 33368517

9

IBD BioResource : an open-access platform of 25 000 patients to accelerate research in Crohn's and Colitis

enthalten in: Gut | 2019

von Parkes, M. | IBD BioResource Investigators | Abdelmalek, E. | +99

10

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease : The Cross Pennine study

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2018

von Lenti, M. | Levison, S. | Eliadou, E. | +20